New drug DR-01 targets hair loss and vitiligo in early trial

NCT ID NCT06602232

Recruiting now Disease control Sponsor: Dren Bio Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 34 times

Summary

This early-phase study tests a new drug, DR-01, in 80 adults with alopecia areata (patchy hair loss) or vitiligo (white patches on skin). The main goals are to check safety and see if the drug can improve hair regrowth or skin color. Participants are randomly assigned to different groups to receive the drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dren Investigational Site
RECRUITING

Northridge, California, 91344, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Miami, Florida, 33155, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Evans, Georgia, 30809, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Meridian, Idaho, 83642, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Indianapolis, Indiana, 46250, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

West Lafayette, Indiana, 47906, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
NOT_YET_RECRUITING

Worcester, Massachusetts, 01605, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Troy, Michigan, 48084, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19103, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
NOT_YET_RECRUITING

Pittsburgh, Pennsylvania, 15213, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Chattanooga, Tennessee, 37421, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

San Antonio, Texas, 78215, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Charlestown, New South Wales, 2290, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Darlinghurst, New South Wales, 2010, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Coorparoo, Queensland, 4151, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

South Yarra, Victoria, 3141, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Fremantle, Washington, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Auckland, 0632, New Zealand

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Christchurch, 8013, New Zealand

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Grafton, 1010, New Zealand

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ALOPECIA AREATA VITILIGO